Legend Biotech (LEGN) Event June 01, 2022, 12:30 UTC (10% Negative) Legend Biotech (LEGN) Reports Q2 2022 Financial Results (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 2:11 p.m. 🌍 Legend Biotech (LEGN) - Form 6-K Filing Filing Date: 2022-06-01 Accepted: 2022-06-01 08:30:34 Event Type: Financial Results Event Details: 1 Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights The U. FDA approval for CARVYKTI, said Ying Huang, Ph. First Quarter 2022 Highlights and Recent Events O. 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2022 2021 Change ($) Change (%) Revenue 40.83K 13.68K $27.14K +198.40% Net Loss -41.09K -80.90K $39.81K +49.21% Cash 377.79K 688.94K $-311.15K -45.16% Assets 1.04M 1.12M $-77.85K -6.96% Liabilities 601.95K 647.16K $-45.21K -6.99% Equity 438.56K 471.21K $-32.64K -6.93% 💼 Business Developments: ✅ Partnership/Collaboration❌ Acquisition Activity: Not reported❌ Licensing Agreement: Not reported✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Email: joanne.choi@legendbiotech.com
🌍 Legend Biotech (LEGN) - Form 6-K Filing
Filing Date: 2022-06-01
Accepted: 2022-06-01 08:30:34
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
📞 Contact Information: